ZiraNyx™ : RNA Drug R&D Modular Platform
ZiraNyx™ is an advanced modular platform for the development of next-generation nucleic acid therapeutics. It integrates four core technology modules—RNA structure design, biomanufacturing, self-assembly, and targeted cellular delivery—to fundamentally improve the production and delivery of RNA-based drugs. By addressing key challenges in efficiency, batch-to-batch consistency, and scalability, ZiraNyx™ offers a streamlined and robust solution for nucleic acid drug development.
ZiraNyx™ offers a robust technology for co-engineering fluorescent labels with functional RNAs and facilitating efficient encapsulation into virus-like particles (VLPs). Importantly, it enables simultaneous packaging of multiple RNA sequences, thereby expanding therapeutic possibilities for complex diseases that require multi-target approaches, such as cancer, viral infections, and autoimmune disorders.
ZiraNyx™ Innovative Application Model
ZiraNyx™ is a versatile platform that provides integrated solutions for the development of nucleic acid products.
Multi-target Precision
Therapeutics
The technology can deliver multiple sets of siRNAs simultaneously, effectively silencing key genes across various disease-related pathways.
Diagnostic Reagent
Development
By combining functional RNA with fluorescent aptamers, this technology can be used to develop highly sensitive and specific biosensing diagnostic tools.
Mechanistic Visualization
Platform
The technology can function as a powerful research tool to observe cellular mechanisms, RNA activity, and gene silencing effects in real time within living cells.
Rapid & Custom for Vaccines or
Gene Therapy
Supports fast, flexible design and production workflows—ideal for early-stage vaccine testing and the development of customized gene therapies.
